The programme aims to address barriers for CROs, enabling them to reduce clinical trial timelines by at least 50%.

AI startup ByteBrain is transforming clinical trials with agent-based optimization, cutting costs, boosting efficiency, and ...

Onsite, the leading provider of point-of-need ophthalmic services for clinical trials, announces the deployment of its latest ...

Behind the veneer of accessibility lies a critical bottleneck in clinical trial readiness, especially pronounced in trials ...

Makary and Prasad also repeat various themes repeatedly visited by Kennedy on his Make America Healthy Again (MAHA) soapbox, ...

Spain’s SpliceBio will use $135 million from a series B round backed by Sanofi and Roche to advance its lead gene editing ...

The new FDA commissioner and Center for Biologics Evaluation and Research (CBER) director laid out their vision for the ...

More than one quarter of the medcines cleared by the FDA’s main review office since 2015 have been cancer drugs, a tally that ...

Blind mice regained vision and monkeys gained infrared sight thanks to a tellurium-based retina implant created by Fudan ...

The TEASE-1 trial reveals gildeuretinol's potential to reduce vision loss in Stargardt disease, offering hope for future ...

Metallic nanoparticles injected into the retina partly restored vision in blind mice and could work as a treatment for ...